Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin Continuation in Ambulatory Surgery
NCT03179254Phase 4Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Mar 2010
- Primary completion
- Jan 2014
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of liquid metformin (Aspargo Labs) in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by UT Southwestern Medical Center. Primary endpoints: Postoperative blood glucose level and Intraoperative and postoperative hypoglycemia. Started Mar 2010; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03179254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03179254.